NOVAVAX INC Sales Agreements
12 Contracts & Agreements
- At Market Issuance Sales Agreement by and among Novavax, Inc., Jefferies LLC and B. Riley Securities, Inc., dated August 8, 2023 (Filed With SEC on August 8, 2023)
- At Market Issuance Sales Agreement between Novavax, Inc. and B. Riley Securities, Inc., dated June 15, 2021 (Filed With SEC on June 15, 2021)
- At Market Issuance Sales Agreement between Novavax, Inc. and B. Riley Securities, Inc., dated January 22, 2021 (Filed With SEC on January 22, 2021)
- At Market Issuance Sales Agreement between Novavax, Inc. and B. Riley Securities, Inc., dated November 10, 2020 (Filed With SEC on November 10, 2020)
- At Market Issuance Sales Agreement between Novavax, Inc. and B. Riley FBR, Inc., dated May 18, 2020 (Filed With SEC on May 18, 2020)
- At Market Issuance Sales Agreement between Novavax, Inc. and B. Riley FBR, Inc., dated March 2, 2020 (Filed With SEC on March 2, 2020)
- At Market Issuance Sales Agreement between Novavax, Inc. and B. Riley FBR, Inc., dated January 21, 2020 (Filed With SEC on January 21, 2020)
- At Market Issuance Sales Agreement between Novavax, Inc. and B. Riley FBR, Inc., dated December 31, 2018 (Filed With SEC on December 31, 2018)
- At Market Issuance Sales Agreement between Novavax, Inc. and B. Riley FBR, Inc., dated December 29, 2017 (Filed With SEC on December 29, 2017)
- EXHIBIT1.1 At MarketIssuance Sales Agreement (Filed With SEC on October 2, 2012)
- At Market Issuance Sales Agreement (Filed With SEC on September 15, 2009)
- At Market Issuance Sales Agreement (Filed With SEC on January 13, 2009)
